📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
HCLTech and Western Union Expand Global Capability Center in Hyderabad for AI Innovation
HCLTech has partnered with Western Union to launch a new Global Capability Center (GCC) in Hyderabad, focusing on AI-led innovation and next-generation payments infrastructure. This facility will leverage HCLTech's proprietary AI Force™ platform to accelerate Western Union's digital transformation and platform operating model. The expansion strengthens HCLTech's footprint in the financial services sector, which is a key contributor to its $14.5 billion annual revenue. This collaboration builds on their existing relationship and complements the existing Pune Tech Center.
Key Highlights
New Global Capability Center (GCC) launched in Hyderabad in collaboration with Western Union.
The facility will utilize HCLTech’s AI Force™ platform to drive engineering excellence and AI innovation.
HCLTech reported consolidated revenues of $14.5 billion for the 12 months ending December 2025.
The company maintains a global workforce of over 226,300 employees across 60 countries.
The center aims to modernize next-generation payments infrastructure and expand consumer services beyond remittances.
💼 Action for Investors
Investors should monitor HCLTech's ability to secure similar high-value GCC partnerships, which provide stable, long-term revenue streams. The focus on AI-led services like AI Force™ suggests a positive shift toward higher-margin digital transformation projects.
Alembic Pharma Receives USFDA Final Approval for Difluprednate Ophthalmic Emulsion
Alembic Pharmaceuticals has secured final USFDA approval for Difluprednate Ophthalmic Emulsion, 0.05%, which is a generic version of Sandoz's Durezol. The product is used for treating inflammation and pain after ocular surgery and for endogenous anterior uveitis. This approval marks a continued expansion of the company's US product portfolio. With this addition, Alembic now holds a cumulative total of 233 USFDA approvals, including 213 final approvals.
Key Highlights
Received final USFDA approval for Difluprednate Ophthalmic Emulsion, 0.05%
Product is therapeutically equivalent to the reference listed drug Durezol by Sandoz Inc.
Indicated for ocular surgery inflammation and endogenous anterior uveitis
Company's cumulative USFDA approvals reach 233 (213 final and 20 tentative)
💼 Action for Investors
Investors should monitor the commercial launch and market share capture of this product in the US ophthalmic market. The steady stream of USFDA approvals remains a key driver for the company's international revenue growth.
RailTel Bags ₹27.04 Crore Order from Andhra Pradesh Central Power Distribution Corp
RailTel Corporation of India has secured a domestic order from Andhra Pradesh Central Power Distribution Corporation Limited (APCPDCL) valued at approximately ₹27.04 crore. The contract involves the supply, installation, testing, and configuration of Software Defined Wide Area Network (SD-WAN) devices along with necessary hardware and licenses. The project includes a long-term commitment with a 5-year warranty and support period, extending the execution timeline to January 2031. This win highlights RailTel's capability in providing specialized IT and networking solutions beyond its core railway operations.
Key Highlights
Total order value is estimated at ₹27,04,21,875 (approx. ₹27.04 Crores)
Contract awarded by Andhra Pradesh Central Power Distribution Corporation Limited
Scope includes SD-WAN device implementation with 5 years of warranty and support
Project execution and support period extends until January 24, 2031
The order is a domestic contract with no promoter or related party interest
💼 Action for Investors
Investors should view this as a positive development that strengthens RailTel's non-railway revenue stream and order book. Maintain a long-term outlook as the company continues to diversify its digital infrastructure portfolio.
All Time Plastics Signs MoU with NECBDC for Engineered Bamboo Development
All Time Plastics Limited (ATPL) has entered into a 3-year non-binding Memorandum of Understanding with the North East Cane and Bamboo Development Council (NECBDC). As a Product and Market Development Partner, ATPL will support the development of engineered bamboo boards and panels in Assam and Nagaland. This initiative leverages ATPL's 37,000 MTPA manufacturing capacity and its export network across 29 countries to create sustainable product lines. The partnership aims to integrate North Eastern bamboo clusters into global supply chains, aligning with the company's material diversification strategy.
Key Highlights
3-year MoU signed with NECBDC under the Ministry of Development of North Eastern Region
ATPL empanelled as a Product and Market Development Partner for engineered bamboo initiatives
Initial focus on ecosystem-level interventions in Assam and Nagaland for product prototyping and manufacturing
Leverages ATPL's existing infrastructure, including a 37,000 MTPA capacity and exports to 29 countries
The collaboration targets high-value structural applications and export-oriented bamboo ecosystems
💼 Action for Investors
Investors should monitor how this MoU translates into definitive commercial agreements and revenue contributions. The focus on sustainable materials could enhance ATPL's ESG profile and appeal to global retailers like IKEA and Tesco.
Ravindra Energy Updates Renewable Pipeline to 235 MW and Secures ₹296 Cr YES Bank Funding
Ravindra Energy Limited (RELTD) has updated its business outlook, reporting an operating renewable capacity of 187 MW DC and a robust pipeline of 235 MW DC. The company is on track to commission 57 MW of MSKVY Phase 2 projects by March 31, 2026, and has secured a Letter of Award for a 71 MW DC project with HESCOM at a tariff of ₹2.93 per unit. In the EV segment, the company achieved 9M FY26 revenue of ₹79.49 crore but reported a PAT loss of ₹6.23 crore. Crucially, YES Bank has sanctioned credit facilities totaling ₹296 crore and a hedge facility of ₹32 crore to support these growth initiatives.
Key Highlights
Operating renewable assets reach 187 MW DC with 60 MW DC currently under construction.
Future pipeline stands at 235 MW DC, including the 150 MW MSKVY Phase 3 and 71 MW HESCOM project.
YES Bank sanctioned ₹296 crore in credit facilities and ₹32 crore in hedge facilities.
EV business recorded 125 vehicle sales and ₹79.49 crore revenue for the nine months ending Dec 2025.
Aims to commission 8 additional EV swap stations by March 2026 to support a 275-vehicle sales pipeline.
💼 Action for Investors
Investors should track the execution of the 57 MW MSKVY Phase 2 projects by the March 2026 deadline and monitor the EV segment's path to break-even. The substantial credit facility from YES Bank significantly de-risks the capital requirements for the upcoming renewable pipeline.
UltraTech Q3 FY26: Normalized PAT Jumps 32% YoY to ₹1,792 Cr; Volumes Up 15%
UltraTech Cement delivered a robust performance in Q3 FY26, with consolidated revenue rising 22.5% YoY to ₹21,506 crores. Consolidated sales volumes grew 15% YoY to 38.87 Mnt, supported by strong demand across housing and infrastructure segments. Operating EBITDA per ton for the UltraTech brand improved by ₹140 YoY to ₹1,051, driven by significant cost reductions in logistics and power. Despite a marginal 0.4% YoY decline in realizations, normalized PAT increased by 32% to ₹1,792 crores.
Key Highlights
Consolidated sales volume increased 15% YoY to 38.87 Mnt, with domestic grey cement growing 15.4%.
Normalized PAT rose 32% YoY to ₹1,792 crores, while consolidated EBITDA grew 29% to ₹4,051 crores.
Logistics and power costs per ton declined by 4% and 15% YoY respectively, helping offset a 6% rise in raw material costs.
Green power mix reached 42.1% of total power consumption, with renewable capacity hitting 1.28GW.
The company recognized a one-time additional impact of ₹88.48 crores due to the implementation of the New Labour Code.
💼 Action for Investors
Investors should maintain a positive outlook as UltraTech demonstrates strong operational leverage and cost leadership in a growing demand environment. The significant improvement in EBITDA per ton and expansion of green energy mix strengthens its long-term competitive position.
UltraTech Cement Q3 FY26: Board Approves Results; Integrates Kesoram and India Cements
UltraTech Cement's Q3 FY26 results reflect a major structural shift following the merger of Kesoram Industries' cement business and the acquisition of India Cements. The company has restated its previous year's figures to include Kesoram's operations from the appointed date of April 1, 2024, to ensure financial comparability. For the quarter ended December 2025, 17 reviewed subsidiaries contributed Rs. 2,310.98 crores to the total revenue. The company continues to treat the significant CCI penalty of Rs. 1,804.31 crores as a contingent liability, backed by legal stay orders.
Key Highlights
Board approved unaudited consolidated financial results for the quarter and nine months ended December 31, 2025.
Financials restated for FY25 to account for the Kesoram Industries merger effective from April 1, 2024.
17 subsidiaries contributed Rs. 2,310.98 crores in revenue and Rs. 211.22 crores in PAT for the quarter.
India Cements Limited results integrated into the consolidated statement following acquisition effective December 24, 2024.
Ongoing legal dispute over CCI penalties totaling approximately Rs. 1,872 crores remains stayed by the Supreme Court.
💼 Action for Investors
Investors should evaluate the operational performance of the newly integrated Kesoram and India Cements assets to gauge synergy benefits. Monitor the Supreme Court's final ruling on the CCI penalty as it represents a significant potential cash outflow.
HCLTech to Acquire Singapore-based Finergic for SGD 19 Million to Boost Wealth Management
HCLTech has signed a definitive agreement to acquire 100% of Finergic Solutions, a Singapore-based boutique wealth consulting firm, for a total cash consideration of SGD 19 million. Finergic reported a revenue of SGD 12.6 million in 2024, showing significant growth from SGD 6.2 million in 2023. The acquisition aims to strengthen HCLTech's digital transformation offerings in the wealth management and core banking sectors. The transaction is expected to be completed by April 30, 2026, and will integrate Finergic's specialized consulting and architecture capabilities into HCLTech's financial services vertical.
Key Highlights
Acquisition of 100% stake in Finergic Solutions for SGD 19 million in an all-cash deal.
Finergic's revenue doubled from SGD 6.2 million in 2023 to SGD 12.6 million in 2024.
Target company reported a Profit After Tax (PAT) of SGD 2.9 million and a Net Worth of SGD 5.4 million for 2024.
Strategic focus on enhancing AI-native workflows and platform-enabled wealth management solutions.
The deal is expected to close by April 30, 2026, expanding HCLTech's footprint in Singapore, Switzerland, and Luxembourg.
💼 Action for Investors
This is a strategic 'tuck-in' acquisition that strengthens HCLTech's high-margin consulting capabilities in the financial services vertical. Investors should view this as a positive move to capture the growing digital transformation spend in global wealth management.
HCLTech to Acquire Singapore-based Finergic for SGD 19 Million to Boost Wealth Management Offerings
HCL Technologies has signed a definitive agreement to acquire 100% of Finergic Solutions, a Singapore-based boutique wealth consulting firm, for SGD 19 million in cash. Finergic reported a significant revenue jump to SGD 12.6 million in 2024 from SGD 6.2 million in 2023, demonstrating strong growth momentum. The acquisition is strategically designed to enhance HCLTech's digital transformation capabilities in the wealth management and core banking sectors, particularly within the Temenos ecosystem. The transaction is expected to be completed by April 30, 2026, and will be executed through HCLTech's wholly-owned subsidiary, HCL Singapore Pte Ltd.
Key Highlights
Acquisition of 100% equity in Finergic Solutions for a total cash consideration of SGD 19 million.
Finergic's revenue doubled year-on-year to SGD 12.6 million in 2024 with a PAT of SGD 2.9 million.
The deal strengthens HCLTech's specialized consulting and wealth-architecture capabilities using AI-native workflows.
Target entity has a global presence in Singapore, Luxembourg, Switzerland, and India.
The acquisition aligns with HCLTech's existing support for over 40 global banks using Temenos products.
💼 Action for Investors
Investors should view this as a positive niche acquisition that adds high-margin consulting capabilities in the growing wealth management tech space. While small relative to HCLTech's total revenue, it strengthens their competitive positioning in the financial services vertical.
Gujarat Gas Submits Revised Amalgamation Scheme Following MCA Directions
Gujarat Gas Limited has submitted a revised Scheme of Amalgamation and Arrangement to comply with directions from the Ministry of Corporate Affairs (MCA). The revisions involve the re-allocation of authorized share capital from Gujarat Gas to GSPL Transmission Limited (GTL) as part of the demerger process. Management has stated that these changes to Clauses 60 and 63 are purely technical and do not affect the rights, interests, or entitlements of shareholders. This update is a procedural step in the larger restructuring of the GSPC group entities, including GSPC, GSPL, and GEL.
Key Highlights
Submission of revised scheme following MCA observations on authorized share capital allocation
Revisions specifically target Clauses 60 and 63 of the composite scheme of arrangement
Management confirms no material impact on the scheme's core terms or shareholder entitlements
The restructuring involves the merger of GSPC, GSPL, and GEL into Gujarat Gas, followed by a demerger
💼 Action for Investors
This is a procedural regulatory update; investors should continue to monitor the final approval timelines for the restructuring as the fundamental swap ratios remain unchanged.
STL Reports Q3 FY26 Revenue Growth of 26% YoY to INR 1,257 Cr; EBITDA Up 16%
Sterlite Technologies (STL) reported a strong year-on-year performance for Q3 FY26, with revenue increasing 26% to INR 1,257 crore and EBITDA rising 16% to INR 129 crore. The growth was primarily driven by the Optical Networking Business, which contributed INR 1,174 crore to the top line, and a significant focus on the US market and AI-ready data center solutions. While YoY metrics improved, EBITDA saw a sequential decline from INR 141 crore in Q2 FY26. The company secured over INR 500 crore in new orders for its data center portfolio during the quarter, highlighting strong momentum in high-growth segments.
Key Highlights
Revenue grew 26% YoY to INR 1,257 Cr, up from INR 998 Cr in the same quarter last year.
EBITDA increased 16% YoY to INR 129 Cr, though it declined sequentially from INR 141 Cr in Q2 FY26.
Optical Networking Business (ONB) recorded revenue of INR 1,174 Cr and EBITDA of INR 131 Cr.
Secured new orders exceeding INR 500 Cr for the Data Centre portfolio to build AI-ready infrastructure.
STL Digital expanded its global footprint to 34 clients, including a multimillion-dollar SAP S/4 HANA deal.
💼 Action for Investors
Investors should focus on the company's successful pivot toward AI-ready data center solutions and the recovery in the US market. While the YoY growth is robust, the sequential dip in EBITDA margins warrants monitoring of operational costs and product mix in upcoming quarters.
LT Foods Launches 'DAAWAT I’m Organic' Range with 100% Traceability Features
LT Foods has expanded its premium portfolio with the launch of the 'DAAWAT® I’m Organic' range, featuring Organic Basmati and Sona Masoori rice. The new range leverages QR-code technology to provide consumers with end-to-end traceability, from geo-tagged cultivation to final packaging. Currently, the organic segment contributes 11% to the company's global revenue, and this launch aims to capture the high-growth health-conscious market in India. LT Foods reported a consolidated revenue of Rs. 8,773 crores in FY'25, maintaining a strong 5-year PAT CAGR of 21%.
Key Highlights
Launched 'DAAWAT® I’m Organic' range featuring Organic Basmati and Sona Masoori rice variants.
Organic Foods & Ingredients business currently contributes 11% to the company's total global revenue.
Introduced industry-first QR-code traceability for geo-tagged cultivation, land testing, and batch certification.
Company reported FY'25 consolidated revenue of Rs. 8,773 crores with a 5-year Revenue CAGR of 16%.
Strategic distribution focus on E-commerce and Quick-commerce platforms to target premium consumers.
💼 Action for Investors
Investors should view this as a positive move toward premiumization and margin expansion within the high-growth organic segment. Monitor the sales traction on Quick-commerce platforms as a lead indicator for the success of this new range.
STL Reports 26% YoY Revenue Growth to INR 1,257 Cr in Q3 FY26
Sterlite Technologies (STL) delivered a robust Q3 FY26 performance with consolidated revenue rising 26% YoY to INR 1,257 Cr. EBITDA grew 16% YoY to INR 129 Cr, although it faced a slight sequential decline from INR 141 Cr in Q2 FY26. The company's Optical Networking Business remains the core driver, contributing INR 1,174 Cr to the top line, while the Data Centre portfolio secured over INR 500 Cr in new orders. STL is successfully pivoting towards high-margin AI-ready digital infrastructure and expanding its global footprint with 34 active digital clients.
Key Highlights
Consolidated revenue increased 26% YoY to INR 1,257 Cr for the quarter ended December 31, 2025.
EBITDA rose 16% YoY to INR 129 Cr, driven by a higher-margin product mix and US market contributions.
Secured new orders exceeding INR 500 Cr in Q3 specifically for next-generation Data Centre solutions.
STL Digital expanded its global client base to 34, including a multimillion-dollar SAP S/4 HANA deal with a US Pharma major.
The company's intellectual property portfolio grew to 780 patents with a focus on Multi-Core and Hollow-Core Fibre technologies.
💼 Action for Investors
Investors should note the strong YoY growth and the company's strategic shift toward high-growth segments like AI-ready Data Centres and the US market. While sequential EBITDA margins showed slight compression, the robust order book and technological leadership in optical connectivity provide a positive long-term outlook.
STL Reports Q3 FY26 Revenue Growth of 26% YoY to INR 1,257 Cr; EBITDA Up 16%
Sterlite Technologies (STL) delivered a strong year-on-year performance in Q3 FY26, with revenue rising 26% to INR 1,257 crore. EBITDA grew 16% YoY to INR 129 crore, although it faced a sequential decline from INR 141 crore in Q2 FY26. The company is aggressively targeting the AI-ready data center market, securing over INR 500 crore in specialized orders this quarter. The Optical Networking Business remains the dominant segment, contributing INR 1,174 crore to the top line.
Key Highlights
Revenue increased 26% YoY to INR 1,257 Cr, showing strong recovery in optical demand.
EBITDA rose 16% YoY to INR 129 Cr, though margins saw a slight sequential dip from Q2 FY26.
Secured new orders exceeding INR 500 Cr for next-generation AI-ready Data Centre infrastructure.
STL Digital expanded its global footprint to 34 clients, including a multimillion-dollar SAP S/4 HANA deal.
Total global patent portfolio reached 780, focusing on innovations like Hollow-Core and Multi-Core Fibre.
💼 Action for Investors
Investors should focus on the company's successful pivot toward high-margin Data Centre and US-based projects which are driving the order book. While sequential EBITDA was slightly lower, the strong YoY revenue growth and positioning for the US BEAD program suggest a positive trajectory.
REC Board to Consider 3rd Interim Dividend for FY 2025-26 on January 29
REC Limited has announced an update to its upcoming Board of Directors meeting scheduled for January 29, 2026. In addition to previously scheduled items, the Board will now consider a proposal for the declaration of a 3rd Interim Dividend for the financial year 2025-26. This follows the company's established practice of frequent dividend distributions to its shareholders. As a Maharatna PSU, REC's dividend decisions are closely watched by income-seeking investors for yield consistency.
Key Highlights
Board meeting scheduled for January 29, 2026, to consider financial results and dividend.
Proposal for the 3rd Interim Dividend for FY 2025-26 is on the agenda.
This update follows an earlier board meeting intimation dated January 19, 2026.
The meeting will be held in compliance with Regulation 29 of SEBI (LODR) Regulations, 2015.
💼 Action for Investors
Investors should monitor the outcome of the January 29 meeting for the dividend amount and the announced record date. REC remains a strong candidate for dividend-yield portfolios given its Maharatna status and consistent payout history.
LTIMindtree Q3 FY26: Revenue Grows 2.4% QoQ to $1.21B; Order Inflow Reaches $1.7B
LTIMindtree reported a steady Q3 FY26 with USD revenue of $1.21 billion, reflecting a 2.4% sequential growth in constant currency despite seasonal furloughs. The company secured a strong order inflow of $1.7 billion, up 6.4% QoQ, highlighted by a significant $155 million deal in the insurance sector. While operational EBIT margins improved slightly to 16.1%, reported PAT was impacted by a one-time labor code charge of ₹590 crores. Management is pivoting towards an 'agentic AI' strategy and has launched the 'New Horizons' program to drive future growth and cost efficiencies.
Key Highlights
Revenue reached USD 1.21 billion, growing 2.4% QoQ in constant currency and 6.1% YoY in USD terms.
Order inflow stood robust at USD 1.7 billion, representing a 6.4% sequential increase.
Adjusted PAT grew 29% YoY to ₹1,401 crores, though reported PAT fell to ₹959 crores due to a ₹590 crore labor code impact.
Operating EBIT margins expanded by 20 bps to 16.1%, driven by the 'Fit4Future' efficiency program.
Net headcount increased by 1,511 to 87,958, including 1,736 freshers, signaling confidence in future demand.
💼 Action for Investors
Investors should focus on the strong deal pipeline and operational margin expansion rather than the one-time labor code hit. The stock remains a solid play on AI-led digital transformation given the management's aggressive 'New Horizons' roadmap.
STL Completes Successful 800 Gbps Multi-Core Fibre Trial with Colt in London
Sterlite Technologies (STL) has successfully completed real-world trials of its Multiverse Multi-Core 4-core Fibre in collaboration with Colt Technology Services in London. The trial achieved an 800 Gbps line rate over distances of 9 km and 63 km, validating the technology for 100GE and 400GE services. This milestone positions STL as a global leader in next-generation optical connectivity, specifically targeting high-demand sectors like AI and hyperscale cloud. The successful validation in a major metro network demonstrates the commercial viability of STL's high-capacity, sustainable fibre solutions.
Key Highlights
Achieved an 800 Gbps line rate during trials on Colt's London metro optical network
Validated 4-core Multi-Core Fibre (MCF) technology over distances of approximately 9 km and 63 km
Successfully tested 100GE and 400GE services with satisfactory results in dispersion and loss measurements
STL's MCF technology packs 4 cores into the same cladding diameter as standard single-mode fibre
Positions STL as one of the first companies globally to transition MCF from laboratory settings to real-world environments
💼 Action for Investors
Investors should view this as a positive technological differentiator that strengthens STL's competitive position in the global AI-ready infrastructure market. Monitor for future commercial contracts resulting from this successful trial with Colt and other global carriers.
TTK Healthcare Q3 Net Profit Drops 37% to ₹10.53 Cr; Impacted by ₹7.58 Cr Exceptional Item
TTK Healthcare reported a 37% year-on-year decline in net profit for Q3 FY26, falling to ₹10.53 crore from ₹16.73 crore. While revenue remained relatively flat at ₹209.30 crore, the bottom line was severely impacted by a one-time exceptional charge of ₹7.58 crore related to the implementation of new Labour Codes. Segment-wise, the Consumer Products and Medical Devices divisions saw margin pressure, while the Protective Devices division continued to report losses. On a positive note, the Foods and Animal Welfare segments showed improved profitability during the quarter.
Key Highlights
Revenue from operations grew marginally by 2.2% YoY to ₹209.30 crore compared to ₹204.74 crore.
Net profit declined 37% YoY to ₹10.53 crore, primarily due to a ₹7.58 crore exceptional charge for labour code adjustments.
Consumer Products segment profit fell sharply to ₹2.25 crore from ₹6.45 crore in the previous year's quarter.
Protective Devices segment recorded a loss of ₹1.10 crore, widening from a loss of ₹0.31 crore YoY.
The company reconstituted its board committees following the retirement of Independent Director Mr. N Ramesh Rajan.
💼 Action for Investors
Investors should monitor the recovery in the Consumer Products segment and the narrowing of losses in the Protective Devices division. While the profit dip is largely due to a non-recurring regulatory charge, the underlying operational weakness in core segments warrants a cautious approach.
TTK Healthcare Q3 Net Profit Drops 37% to ₹10.53 Cr; Impacted by ₹7.58 Cr Exceptional Item
TTK Healthcare reported a 37% year-on-year decline in net profit for Q3 FY26, falling to ₹10.53 crore from ₹16.73 crore. The bottom line was significantly impacted by a one-time exceptional charge of ₹7.58 crore related to the implementation of new Labour Codes affecting gratuity and leave provisions. While revenue from operations remained relatively flat at ₹209.30 crore, the Protective Devices segment continued to struggle, reporting a loss of ₹1.10 crore. Conversely, the Animal Welfare and Medical Devices segments showed healthy revenue growth during the quarter.
Key Highlights
Net Profit for Q3 FY26 fell 37% YoY to ₹1,053.26 lakhs compared to ₹1,673.24 lakhs in the previous year.
Revenue from operations grew marginally by 2.2% YoY to ₹20,929.89 lakhs.
Recognized a net exceptional charge of ₹757.87 lakhs due to the incremental impact of new Labour Codes on employee benefits.
Protective Devices segment reported a loss of ₹110.23 lakhs, continuing a trend of underperformance.
Animal Welfare and Medical Devices segments saw revenue growth of 15.5% and 19.1% YoY respectively.
💼 Action for Investors
Investors should monitor the recovery in the Protective Devices segment and the stabilization of margins following the one-time labour code adjustments. The stock may face short-term pressure due to the sharp decline in quarterly profitability.
TTK Healthcare Q3 Net Profit Falls 37% to ₹10.53 Cr Due to ₹7.58 Cr Exceptional Labour Code Charge
TTK Healthcare reported a marginal 2.2% YoY growth in revenue from operations to ₹209.30 crore for Q3 FY26. However, Net Profit declined significantly by 37% YoY to ₹10.53 crore, primarily impacted by a one-time exceptional charge of ₹7.58 crore related to the implementation of new Labour Codes. While the Foods and Animal Welfare segments showed improved profitability, the core Consumer Products and Medical Devices divisions faced margin pressure, and the Protective Devices segment continued to report losses.
Key Highlights
Revenue from operations grew slightly to ₹209.30 crore in Q3 FY26 from ₹204.74 crore in Q3 FY25.
Net Profit dropped 37% YoY to ₹10.53 crore, down from ₹16.73 crore in the same quarter last year.
Recognized a net exceptional charge of ₹757.87 lakhs for incremental Gratuity and Long-term Compensated Absences following new Labour Code notifications.
Consumer Products segment profit slumped to ₹2.25 crore from ₹6.45 crore YoY, indicating significant margin pressure.
Foods segment performed strongly with profit rising to ₹3.40 crore compared to ₹1.43 crore in the previous year's quarter.
💼 Action for Investors
The profit decline is largely attributed to a non-recurring regulatory accounting charge; however, the sharp drop in Consumer Products margins is a fundamental concern. Investors should monitor if the growth in the Foods segment can offset the volatility in the Protective and Consumer product divisions.